Beyond the wheelchair. Beyond every limit.
PathStrider is the world's first intelligent seated robotic independence platform — a single integrated medical device replacing the power wheelchair, the Hoyer lift, the transfer board, the pressure relief cushion, and hours of caregiver assistance every day.
Daily life for full-time wheelchair users still depends on a fragmented stack of equipment and unpaid labor.
For users with SMA, ALS, spinal cord injury, MS, and other complex conditions, real independence is blocked by gaps the existing market has not addressed.
Stopped at the Edge
Standard power chairs fail at curbs, gravel, dirt trails, roots, and slopes — excluding users from outdoor life.
Hours of Caregiver Time
Transfers, repositioning, and ROM stretching consume 4–8 hours of paid or family caregiver time daily.
Pressure Injury Risk
Sustained sitting causes pressure sores that lead to hospitalization. Existing cushions are passive and reactive.
The Hoyer Lift
Mechanical patient lifts require a second person, take 10+ minutes per transfer, and strip dignity from a daily routine.
A single integrated medical device. Seven systems replaced.
Engineered for users who never stand. Powered by NVIDIA Jetson Thor compute, governed by safety-first force limits designed specifically for fragile neuromuscular conditions.
7+1 DOF therapy-grade robotic arms with 20 lb payload
Stair climbing and rough terrain navigation
Integrated sliding board eliminates the Hoyer lift
Carbon fiber transfer board — independent transfers
Hybrid Wheel-Leg Locomotion
Wheels for indoors. Locked feet for outdoor terrain. One platform, every surface.
360° Powered Seat with 3-Axis Gimbal
Active stabilization keeps the seat level on slopes and rough ground.
AI Pressure-Mapping Seat
64-point sensor array continuously redistributes pressure to prevent injury.
7+1 DOF Therapy-Grade Robotic Arms
20 lb payload per arm. Telescoping reach delivers documented PT protocols on demand.
Integrated Transfer System
Deployable carbon fiber transfer board with coordinated robotic arm stabilization eliminates the Hoyer lift.
AI Intelligence Stack
NVIDIA Jetson Thor compute for real-time terrain analysis, pressure relief, and predictive assistance.
Multi-Modal Control
Joystick, voice, EMG, eye-tracking, head array, and BCI-compatible interfaces.
A clear 36–42 month path to FDA clearance and CMS reimbursement.
PathStrider is engineered from day one to meet Complex Rehabilitation Technology coverage criteria. Clinical evidence collection begins during the prototype phase.
Foundation
- ASU Capstone V1 prototype build
- 10–15 user clinical pilot study
- Outcome and usage data collection
- FDA De Novo classification filing
Clinical & Regulatory
- Multi-site clinical study (50+ users)
- FDA De Novo submission
- HCPCS Level II code application
- Early payer engagement
Commercialization
- FDA clearance secured
- CRT designation & HCPCS code
- CRT supplier distribution partnerships
- Initial Medicare coverage decisions
Tyrone Ellis II
SMA Wheelchair User & Founder
Born with Spinal Muscular Atrophy (diagnosed at 3), I've spent 28 years navigating the daily limitations of existing wheelchairs. After one too many struggles with transfers, pressure sores, and being stuck at the edge of trails, I decided to build the device I've always needed.
"PathStrider isn't just a product — it's a personal mission to give people with complex disabilities true independence and freedom."
2 Provisional Patents Filed
USPTO — Platform Architecture & Medical Device
Intellectual property protection covering the integrated hybrid locomotion platform and the autonomous transfer system.
Backed By
ASU Fulton Schools of Engineering
Capstone Team Fall 2026 – Spring 2027
Microsoft for Startups
$150K Azure Credits & Enterprise Stack
USPTO
2 Provisional Patents Filed
Be among the first considered when PathStrider is available for clinical fitting.
For wheelchair users, families, clinicians, and CRT suppliers. We will reach out when the prototype is ready for trial and when clinical study slots open.
Interested in being an early tester?
Help us shape the future of assistive mobility. Share your details and we will prioritize you for our clinical pilot program.